Summary
43 / 100 · Bulios Score
What speaks for it
- The price moves less than the market (beta 0.63).
What to watch
- Revenue fell by 20% a year over the last 3 years.
- The company made a loss over the last 12 months.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (CAD)
Diluted EPS (CAD)
Revenue fell by 20% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
The company reports no revenue by product.
By region
- Canada 62%
- Europe 23%
- Africa 13%
- Asia 2.3%
Canada brings in 62% of revenue. Asia grew fastest, by 39% a year.
Segments in detail